- Home
- GOGO vs ORGO Comparison
GOGO vs ORGO Comparison
Compare GOGO & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOGO | ORGO |
|---|---|---|
| Founded | 1991 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 701.4M | 732.3M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | GOGO | ORGO |
|---|---|---|
| Price | $4.80 | $3.90 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $14.00 | $8.00 |
| AVG Volume (30 Days) | ★ 3.2M | 1.3M |
| Earning Date | 11-06-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $817,729,000.00 | $465,218,000.00 |
| Revenue This Year | $107.31 | $8.14 |
| Revenue Next Year | $1.84 | $6.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 102.05 | 2.24 |
| 52 Week Low | $4.44 | $2.61 |
| 52 Week High | $16.82 | $7.08 |
Technical Indicators
Market Signals| Indicator | GOGO | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 38.22 | 29.19 |
| Support Level | $4.77 | $4.24 |
| Resistance Level | $5.34 | $4.28 |
| Average True Range (ATR) | 0.26 | 0.23 |
| MACD | 0.11 | -0.12 |
| Stochastic Oscillator | 40.56 | 3.76 |
Price Performance
Historical ComparisonAbout GOGO Gogo Inc.
Gogo Inc is a broadband connectivity service for the business aviation market. It provides a customizable suite of smart cabin systems for integrated connectivity, inflight entertainment, and voice solutions. Its business segment includes Gogo BA and Satcom Direct. It generates two types of revenue: service revenue consists of monthly subscription and usage fees paid by aircraft owners and operators for telecommunication, data, and in-flight entertainment services, and equipment revenue consists of proceeds from the sale of ATG and narrowband satellite connectivity equipment and is recognized when control of the equipment is transferred to OEMs and dealers, which generally occurs when the equipment is shipped.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.